Search results
Type 2 diabetes: New guidelines on using GLP-1 drugs such as Ozempic
Medical News Today· 6 days agoResearchers report that GLP-1 and SGLT-2 drugs can help people with type 2 diabetes control blood...
Does Alcohol Increase Your Risk of Type 2 Diabetes?
EatingWell· 14 hours agoAlcohol gets a bad rap for a lot of reasons, but does it really raise your risk of diabetes? Nearly 1 in every 10 Americans develops diabetes, most of...
Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors
Medical Xpress· 11 hours agoPublished in the Journal of Clinical Oncology, their work also found an association between a...
Updates in Managing Elderly Patients With Type 2 Diabetes
Medscape· 1 day agoThe SFD has updated its position statement on type 2 diabetes every 2 years since 2017. A chapter is...
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
CNN via Yahoo News· 2 hours ago“The scientists at Novo Nordisk deserve great credit for developing these drugs that have the...
Type 2 diabetes is not one-size-fits-all: Subtypes affect complications and treatment options -...
EconoTimes· 6 days agoYou may have heard of Ozempic, the “miracle drug” for weight loss, but did you know that it was...
2 Best Hydrating Foods To Eat Every Day To Stay Full Longer And Lose Weight Faster, Dietitians Say:...
SheFinds via Yahoo News· 7 hours agoHydration is essential for overall health and well-being, but did you know that certain foods can...
May 2 elections: The local, mayoral and police contests to watch
Press Association News via AOL· 4 hours agoEvery voter in England and Wales will be able to cast a ballot in at least one type of election on...
Common foods including bread that have been linked to diabetes
Daily Express· 11 hours agoNew research shows that certain additives found in common ultra-processed foods could increase the...
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of...
FOX 23 News Albany· 19 hours agoAlkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo ...